Imbed Biosciences Inc. is a privately held medical device company emerging as a leader in the development of advanced therapies for the treatment of burns, chronic ulcers, gastro-intestinal defects, and soft-tissue repair. The company has a portfolio of products in development based on its patented MicroLyte® Matrix technology that presents bioactive molecules on tissue surfaces to combat local pain and infections. The microscale matrix accelerates cell migration and reduces antibiotic/opioid abuse. Company is registered with U.S. FDA as a medical device manufacturer and maintains an ISO 13485 certified Quality Management System. For more information, please visit www.imbedbio.com, www.MicrolyteMatrix.com, facebook.com/imbedbio, and follow @ImbedBio and @MicroLyteAgMtrx on twitter.
Company’s Keywords:
medical devices, nanocoatings, silver nanoparticles, wound care, chronic wounds, soft tissue repair, biotech, surgical
<40
<
<2012